Myelodysplastic syndromes: moving towards personalized management
The myelodysplastic syndromes (MDS) share their origin in the hematopoietic stem cell but have otherwise very heterogeneous biological and genetic characteristics. Clinical features are dominated by cytopenia and a substantial risk for progression to acute myeloid leukemia. According to the World He...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2020-07-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/9929 |